Viatris Inc (VTRS)
10.60
+0.12
(+1.14%)
USD |
NASDAQ |
May 31, 16:00
10.60
0.00 (0.00%)
After-Hours: 20:00
Viatris Cash from Investing (Quarterly): -154.30M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -154.30M |
December 31, 2023 | 115.80M |
September 30, 2023 | -53.80M |
June 30, 2023 | -76.60M |
March 31, 2023 | -749.50M |
December 31, 2022 | 1.784B |
September 30, 2022 | -115.00M |
June 30, 2022 | -82.10M |
March 31, 2022 | -66.90M |
December 31, 2021 | -219.10M |
September 30, 2021 | -118.20M |
June 30, 2021 | -16.80M |
March 31, 2021 | 236.30M |
December 31, 2020 | -22.30M |
September 30, 2020 | -58.70M |
June 30, 2020 | -74.50M |
March 31, 2020 | -145.60M |
December 31, 2019 | -114.50M |
September 30, 2019 | -176.90M |
June 30, 2019 | -158.40M |
March 31, 2019 | -75.60M |
December 31, 2018 | -175.60M |
September 30, 2018 | -302.10M |
June 30, 2018 | -303.80M |
March 31, 2018 | -428.90M |
Date | Value |
---|---|
December 31, 2017 | -220.70M |
September 30, 2017 | -126.90M |
June 30, 2017 | -452.00M |
March 31, 2017 | -176.80M |
December 31, 2016 | -596.20M |
September 30, 2016 | -5.780B |
June 30, 2016 | -1.141B |
March 31, 2016 | -160.00M |
December 31, 2015 | -930.40M |
September 30, 2015 | -371.50M |
June 30, 2015 | -180.30M |
March 31, 2015 | -87.50M |
December 31, 2014 | -83.40M |
September 30, 2014 | -397.60M |
June 30, 2014 | -118.10M |
March 31, 2014 | -201.20M |
December 31, 2013 | -1.506B |
September 30, 2013 | -132.00M |
June 30, 2013 | -88.90M |
March 31, 2013 | -142.30M |
December 31, 2012 | -146.37M |
September 30, 2012 | -51.94M |
June 30, 2012 | -57.66M |
March 31, 2012 | -108.22M |
December 31, 2011 | -178.99M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-749.50M
Minimum
Mar 2023
1.784B
Maximum
Dec 2022
-13.33M
Average
-79.35M
Median
Cash from Investing (Quarterly) Benchmarks
Pfizer Inc | 1.732B |
Johnson & Johnson | -464.00M |
QuidelOrtho Corp | -20.20M |
Iovance Biotherapeutics Inc | -111.51M |
Evolus Inc | -0.797M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 614.60M |
Cash from Financing (Quarterly) | -425.60M |
Free Cash Flow | 2.000B |
Free Cash Flow Per Share (Quarterly) | 0.4661 |
Free Cash Flow to Equity (Quarterly) | 724.40M |
Free Cash Flow to Firm (Quarterly) | 640.85M |
Free Cash Flow Yield | 15.62% |